Navigating the Complex Treatment Landscape in Relapsed/Refractory Myeloma

Review the latest evidence-based strategies on individualized treatment of relapsed/refractory multiple myeloma with downloadable slides a podcast and an on-demand webcast from a live CCO webinar.

Share

Program Content

Activities

Therapy After Multiple Relapses
Relapsed/Refractory Multiple Myeloma: Subsequent Therapy and Beyond
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2022

Expires: September 21, 2023

Treating First Relapse in MM
Current Treatment Options at First Relapse in Relapsed/Refractory Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2022

Expires: September 21, 2023

CAR T-Cells, Bispecifics in MM
CAR T-Cells and Bispecific Antibodies in MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2022

Expires: September 21, 2023

<i>EP</i>: Treatment for RR MM
ExpressPoints:
Navigating the Complex Treatment Landscape in Relapsed/Refractory Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2022

Expires: September 21, 2023

No activities added yet

Activities

Treating Relapsed/Refractory Myeloma
Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 24, 2022

Expires: October 23, 2023

Faculty

cover img faculity

Natalie S. Callander, MD

Professor of Medicine
School of Medicine and Public Health
University of Wisconsin
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin

cover img faculity

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Janssen administered by Scientific Affairs

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.